IP Library Granted Patent US 12,605,515
Granted Patent B1
US 12,605,515 · App. 18/063,237 · Granted Apr 21, 2026

Aerosol delivery device with completed dosage indicator

Inventors: Matthew Gravett (London, CA); Daniela Manotas (London, CA); Hannah Hammond (Hamilton, CA); Robert Frank Costa (London, CA)
Assignee: Trudell Medical International Inc.
A61M15/008A61M15/0086A61M16/208A61M2205/581
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,605,515
App. No.
18/063,237
Granted
Apr 21, 2026
Kind
B1
Abstract

A medication delivery system includes a chamber housing defining an interior volume. The chamber housing has an inlet adapted to receive a dosage of medicament and an outlet spaced apart from the inlet. The inlet and outlet are in fluid communication with the interior volume. A flow channel is in fluid communication with the interior volume. A dosage indicator is translatable in the flow channel from a pre-inhalation position to a complete dosage position, wherein a positioning of the dosage indicator in the complete dosage position indicates a complete administration of the dosage of medicament through the outlet. Methods of using and assembling the system are also provided.

Claims (31)

1 . A medication delivery system comprising:

a chamber housing defining an interior volume and comprising an inlet adapted to receive a dosage of medicament and an outlet spaced apart from the inlet, wherein the inlet and outlet are in fluid communication with the interior volume;

a flow channel in fluid communication with the interior volume; and

a dosage indicator translatable in the flow channel from a pre-inhalation position to a complete dosage position, wherein a positioning of the dosage indicator in the complete dosage position indicates a complete administration of the dosage of medicament through the outlet, wherein the dosage indicator is visible through the flow channel as the dosage indicator is translated between the pre-inhalation position and the complete dosage position;

wherein the dosage indicator comprises a turbine, wherein the turbine is rotatable as the turbine is translated from the pre-inhalation position to the complete dosage position.

2 . The medication delivery system of claim 1 wherein the dosage indicator is translatable along a linear path between the pre-inhalation position and the complete dosage position.

3 . The medication delivery system of claim 1 further comprising a user interface coupled to the chamber housing, wherein the dosage indicator is closer to the user interface in the pre-inhalation position than in the complete dosage position.

4 . The medication delivery system of claim 1 wherein the inlet and outlet are spaced apart in a longitudinal direction, wherein the flow channel extends in the longitudinal direction, wherein the turbine is rotatable about a rotation axis extending transverse to the longitudinal direction, and wherein the rotation axis is translatable in the longitudinal direction.

5 . The medication delivery system of claim 1 further comprising an auditory indicator adapted to provide an audible signal when the dosage indicator is translated to the complete dosage position.

6 . The medication delivery system of claim 5 wherein the dosage indicator is the auditory indicator.

7 . The medication delivery system of claim 1 wherein the flow channel comprises a track, wherein the turbine is moveable along the track between the pre-inhalation position and the complete dosage position.

8 . The medication delivery system of claim 7 wherein the track comprises a rack, and wherein the turbine comprises a pinion gear rotatably engaging the rack.

9 . The medication delivery system of claim 7 wherein the track comprises a dip adjacent the dosage indicator when positioned in the pre-inhalation position.

10 . The medication delivery system of claim 1 further comprising an adaptor coupled to the chamber housing, wherein the inlet comprises a first inlet defined by the adapter, and wherein the adapter further comprises a second inlet communicating with the interior volume, the second inlet comprising a variable size opening.

11 . The medication delivery system of claim 10 wherein the variable size opening is defined by a one-way inhalation valve disposed over the second inlet.

12 . The medication delivery system of claim 10 wherein the variable size opening is defined by a dial moveable relative to the second inlet.

13 . The medication delivery system of claim 10 wherein the flow channel is in fluid communication with the interior volume at a third inlet spaced apart from the first and second inlets.

14 . The medication delivery system of claim 10 wherein the flow channel is in fluid communication with the interior volume at a third inlet spaced apart from the first and second inlets.

15 . A medication delivery system comprising:

a chamber housing defining an interior volume and comprising an inlet adapted to receive a dosage of medicament and a user interface spaced apart from the inlet in a longitudinal direction, wherein the inlet and the user interface are in fluid communication with the interior volume;

a flow channel in fluid communication with the interior volume and extending in the longitudinal direction; and

a dosage indicator translatable in the flow channel from a pre-inhalation position proximate the user interface to a complete dosage position proximate the inlet, wherein a positioning of the dosage indicator in the complete dosage position indicates a complete administration of the dosage of medicament through the user interface, wherein the dosage indicator comprises a turbine that is rotatable in, and visible through, the flow channel as the dosage indicator is translated between the pre-inhalation position and the complete dosage position.

16 . The medication delivery system of claim 15 wherein the dosage indicator is translatable along a linear path between the pre-inhalation position and the complete dosage position.

17 . The medication delivery system of claim 15 further comprising an auditory indicator adapted to provide an audible signal when the dosage indicator is translated to the complete dosage position.

18 . The medication delivery system of claim 17 wherein the turbine is the auditory indicator.

19 . The medication delivery system of claim 15 wherein the flow channel comprises a track, wherein the turbine is translatable along, and rotatable on, the track between the pre-inhalation position and the complete dosage position.

20 . The medication delivery system of claim 19 wherein the track comprises a rack, and wherein the turbine comprises a pinion gear rotatably engaging the rack.

21 . The medication delivery system of claim 19 wherein the track comprises a dip adjacent the dosage indicator when positioned in the pre-inhalation position.

22 . The medication delivery system of claim 15 further comprising an adaptor coupled to the chamber housing, wherein the inlet comprises a first inlet defined by the adapter, and wherein the adapter further comprises a second inlet communicating with the interior volume, the second inlet comprising a variable size opening.

23 . The medication delivery system of claim 22 wherein the variable size opening is defined by a one-way inhalation valve disposed over the second inlet.

24 . The medication delivery system of claim 22 wherein the variable size opening is defined by a dial moveable relative to the second inlet.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 3, 2024
From: TRUDELL MEDICAL INTERNATIONAL; TRUDELL PARTNERSHIP HOLDINGS LIMITED; PACKARD MEDICAL SUPPLY CENTRE LTD
To: TRUDELL MEDICAL INTERNATIONAL INC.
Reel/Frame 067003/0423 →
CORRECTIVE ASSIGNMENT TO CORRECT THE THE 4TH INVENTOR'S NAME PREVIOUSLY RECORDED AT REEL: 062029 FRAME: 0883. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Dec 19, 2022
From: GRAVETT, MATTHEW; MANOTAS, DANIELA; HAMMOND, HANNAH; COSTA, ROBERT FRANK
To: INTERNATIONAL, TRUDELL M
Reel/Frame 062153/0693 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2022
From: GRAVETT, MATTHEW; MANOTAS, DANIELA; HAMMOND, HANNAH; COSTA, ROB
To: TRUDELL MEDICAL INTERNATIONAL
Reel/Frame 062029/0883 →
Continuity (1)
Provisional Application 63288198 · Dec 10, 2021
References Cited (14)
US 5522380A · Dwork · 1996 [cited by examiner]
US 5839430A · Cama · 1998 [cited by examiner]
US 6073628A · Butler et al. · 2000 [cited by applicant]
US 8464706B2 · Crockford et al. · 2013 [cited by applicant]
US 8550067B2 · Bruce et al. · 2013 [cited by applicant]
US 8820316B2 · Crockford et al. · 2014 [cited by applicant]
US 20150265874A1 · Rettig, Jr. · 2015 [cited by examiner]
US 20170333645A1 · Alizoti et al. · 2017 [cited by applicant]
US 20190059811A1 · Dashiell · 2019 [cited by examiner]
US 20190366018A1 · Conlon et al. · 2019 [cited by applicant]
US 20200390988A1 · Lim · 2020 [cited by examiner]
US 20210045657A1 · Thomas · 2021 [cited by examiner]
EP 1201258 · 2022 [cited by applicant]
Medgadget, “Watchhaler to Turn Inhalation Into Child's Play”, Jul. 17, 2008, https://www.medgadget.com/2008/07/watchhaler_to_turn_inhalation_into_childs_play.html (2 pages). [cited by applicant]